Neurology
Latest News
Measuring Sleepiness in Patients With OSA
Panelists discuss how they approach measuring sleepiness in patients with OSA, with emphasis on trusting patient reports over relying solely on object...
Treatment Selection for EDS in Patients With OSA
Panelists discuss how they select between wake-promoting medications (modafinil, armodafinil, and solriamfetol) by explaining neurotransmitter mechani...
AAIC 2025 Preclinical Results of Anti-Tau Antibody MK-2214 in Alzheimer Disease: Jonathan Sugam, PhD
The principal scientist of neuroscience discovery at Merck presented preclinical data at AAIC 2025 supporting the development of MK-2214, an anti-tau...
This Week on NeurologyLive® — August 18, 2025
Here's some of what is coming soon to NeurologyLive® this week.
Booze, Bubbles, and Blood Sugar Trouble
Nonalcoholic beer often contains more carbohydrates than regular beer; here’s what that means for blood sugar control. Medscape News UK
Electronic Health Record Study Finds No Significant Cardiovascular Risk With Triptan Use for Migraine
A recent study reassured that triptans may be safe for migraine treatment, emphasizing the need for individualized assessments of cardiovascular risks...
Building Empathy Through Patient-Centered Simulations: Perspectives From 2025 ATMRD Congress
At the 2025 ATMRD Congress, Anissa Mitchell, LCSW, chief program officer at PMD Alliance, discussed immersive, patient-focused sessions aimed at impro...
NeurologyLive® Brain Games: August 17, 2025
Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics....
Building a Clinical Trial Framework to Study GLP-1 RAs in Stroke-Related Conditions: Dennis Rivet, MD
The Harold I. Nemuth Chair in Neurological Disorders at Virginia Commonwealth University discussed the next steps in advancing GLP-1s for idiopathic i...
Overviewing 36-Month, Phase 1b Data Testing Gene Therapy AB-1005 in Parkinson Disease: Nisha Chhabria MD, FAAN
The medical director of CNS Clinical Development at AskBio discussed long-term data presented at ATMRD from the company’s phase 1b assessing the inves...
Measuring Sleepiness in Patients With OSA
Treatment Selection for EDS in Patients With OSA
AAIC 2025 Preclinical Results of Anti-Tau Antibody MK-2214 in Alzheimer Disease: Jonathan Sugam, PhD
This Week on NeurologyLive® — August 18, 2025
Booze, Bubbles, and Blood Sugar Trouble
Electronic Health Record Study Finds No Significant Cardiovascular Risk With Triptan Use for Migraine
Building Empathy Through Patient-Centered Simulations: Perspectives From 2025 ATMRD Congress
NeurologyLive® Brain Games: August 17, 2025
Building a Clinical Trial Framework to Study GLP-1 RAs in Stroke-Related Conditions: Dennis Rivet, MD
Overviewing 36-Month, Phase 1b Data Testing Gene Therapy AB-1005 in Parkinson Disease: Nisha Chhabria MD, FAAN
Advertisement
300x250 Banner
Recent Content
COPD Biologics: Early Treatment Insights
Pulmonology • 2 hours ago
Antihypertensive Medication Guidelines
Cardiology • 4 hours ago
Juvenile Arthritis Care Transition
Rheumatology • 6 hours ago